Mengmeng Long

588 total citations
11 papers, 411 citations indexed

About

Mengmeng Long is a scholar working on Biomedical Engineering, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Mengmeng Long has authored 11 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomedical Engineering, 4 papers in Materials Chemistry and 3 papers in Molecular Biology. Recurrent topics in Mengmeng Long's work include Nanoplatforms for cancer theranostics (6 papers), Advanced Nanomaterials in Catalysis (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Mengmeng Long is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Advanced Nanomaterials in Catalysis (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Mengmeng Long collaborates with scholars based in China, United States and Germany. Mengmeng Long's co-authors include Ning Gu, Hongliang He, Li Zhu, Zhongping Chen, Ailing Lu, Yi Li, Lei Cui, Yifan Duan, Lingyan Weng and Min Lü and has published in prestigious journals such as ACS Nano, Biomaterials and Advanced Functional Materials.

In The Last Decade

Mengmeng Long

10 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengmeng Long China 9 224 144 128 118 61 11 411
Nengyi Ni Singapore 11 257 1.1× 119 0.8× 125 1.0× 164 1.4× 28 0.5× 20 429
Zian Pan China 12 219 1.0× 122 0.8× 91 0.7× 92 0.8× 36 0.6× 19 347
Kai Deng China 12 278 1.2× 124 0.9× 125 1.0× 120 1.0× 45 0.7× 30 467
Chunfang Wei China 8 278 1.2× 161 1.1× 134 1.0× 207 1.8× 24 0.4× 10 554
Yongjun Wang China 5 242 1.1× 197 1.4× 223 1.7× 77 0.7× 65 1.1× 13 472
Gemma Marston United Kingdom 10 197 0.9× 99 0.7× 65 0.5× 82 0.7× 50 0.8× 18 433

Countries citing papers authored by Mengmeng Long

Since Specialization
Citations

This map shows the geographic impact of Mengmeng Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengmeng Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengmeng Long more than expected).

Fields of papers citing papers by Mengmeng Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengmeng Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengmeng Long. The network helps show where Mengmeng Long may publish in the future.

Co-authorship network of co-authors of Mengmeng Long

This figure shows the co-authorship network connecting the top 25 collaborators of Mengmeng Long. A scholar is included among the top collaborators of Mengmeng Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengmeng Long. Mengmeng Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Long, Mengmeng, Lintao Wang, Lina Kang, et al.. (2025). Prussian Blue Nanozyme Featuring Enhanced Superoxide Dismutase-like Activity for Myocardial Ischemia Reperfusion Injury Treatment. ACS Nano. 19(4). 4561–4581. 16 indexed citations
2.
Ding, He, Mengmeng Long, Yuehuang Wu, et al.. (2025). Subcellular distribution of Prussian blue nanozymes dictates enzymatic activity and macrophage polarization for effective colitis therapy. Biomaterials. 325. 123622–123622.
3.
Lü, Kun, et al.. (2025). Prussian Blue Nanozyme-Functionalized Hydrogel with Self-Enhanced Redox Regulation for Accelerated Wound Healing. ACS Applied Materials & Interfaces. 17(25). 36511–36520. 2 indexed citations
4.
Long, Mengmeng, Yan Li, Hongliang He, & Ning Gu. (2023). The Story of Ferumoxytol: Synthesis Production, Current Clinical Applications, and Therapeutic Potential. Advanced Healthcare Materials. 13(6). e2302773–e2302773. 30 indexed citations
5.
He, Hongliang, Mengmeng Long, Yifan Duan, & Ning Gu. (2023). Prussian blue nanozymes: progress, challenges, and opportunities. Nanoscale. 15(31). 12818–12839. 55 indexed citations
6.
He, Hongliang, Shi Wang, Mengmeng Long, et al.. (2023). Design of a Multifunctional Nanozyme for Resolving the Proinflammatory Plaque Microenvironment and Attenuating Atherosclerosis. ACS Nano. 17(15). 14555–14571. 66 indexed citations
7.
Liu, Dong, Mengmeng Long, Yanjun Chen, et al.. (2022). Nanomedicines Targeting Respiratory Injuries for Pulmonary Disease Management. Advanced Functional Materials. 32(22). 25 indexed citations
8.
Long, Mengmeng, Xu Huang, Min Lü, et al.. (2021). Alendronate-functionalized hypoxia-responsive polymeric micelles for targeted therapy of bone metastatic prostate cancer. Journal of Controlled Release. 334. 303–317. 63 indexed citations
9.
Long, Mengmeng, Ailing Lu, Min Lü, et al.. (2020). Azo-inserted responsive hybrid liposomes for hypoxia-specific drug delivery. Acta Biomaterialia. 115. 343–357. 35 indexed citations
10.
Long, Mengmeng, Qiuping Chen, Yapeng Lu, et al.. (2019). Development of β-elemene and Cisplatin Co-Loaded Liposomes for Effective Lung Cancer Therapy and Evaluation in Patient-Derived Tumor Xenografts. Pharmaceutical Research. 36(8). 121–121. 23 indexed citations
11.
Li, Yi, Ailing Lu, Mengmeng Long, et al.. (2018). Nitroimidazole derivative incorporated liposomes for hypoxia-triggered drug delivery and enhanced therapeutic efficacy in patient-derived tumor xenografts. Acta Biomaterialia. 83. 334–348. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026